FDA warns about unapproved medications from a Canadian supplier

.

FDA warns about unapproved medications from a Canadian supplier

The U. S. Food & Drug Administration (FDA) has warned more than 350 medical practices that they might have received unapproved, counterfeit or unsafe medications from a Canadian supplier.

The federal food and drugs regulator said that the medications, including unapproved variants of Botox, could harm patients as they could be counterfeit or contaminated.

The foreign supplier who allegedly supplied the unapproved medications to the U. S. medical practices is operated by Canada Drugs, which is also called Quality Specialty Products (QSP), QP Medical or Bridgewater Medical.

In the letter written to the medical practices, the federal agency said, "FDA is very concerned that products distributed by these suppliers may cause harm to patients, because they may be unsafe or ineffective."

The FDA also warned doctors about purchasing drugs from any source other than pharmacies licensed by the U. S. authorities.

Dr. Peter B. Fodor, a plastic surgeon and an expert on Botox, also warned that using a non-FDA approved Botox could be very dangerous.

This is the fifth warning issued by the FDA this year about a foreign supplier supplying unapproved medications.

 


Latest News

Third-Quarter Sales Better -Than- Expected for LinkedIn, Thanks to New Businesse
“Overweight” Rating for Facebook from JPMorgan Chase & Co
Fall in Oil prices Leave the Small-cap Shale Companies in Trouble
Beginning of 2015, Starbucks will Start its Delivery Service in Selected Markets
Herb Strather, Detroit blight Buyer Makes a Wednesday Deadline
Baidu with its Growing Mobile Presence, Hit 27 Percent Profit Increase
Third Quarter Profits for Samsung Electronics Drop Sharply
Federal Reserve Ends Bond Buying Programme, Keeps Interest Rates Low
Reduced Growth in Major Overseas Economies Affect U.S. Durable Goods Order
Lowe’s to Introduce Robots in Store for Customer Service
Facebook Shares Fall as the Company Portrays Increased in Expenses in 2015
USPS Audit Questions the Consistency of Surveillance Conducted on Mail